David Encinas-Basurto, Priya Muralidharan, M D Saiful Islam, Ernest L Vallorz, Stephen M Black, Monica Kraft, Julie G Ledford, Heidi M Mansour
{"title":"肺表面活性剂SP-A肽模拟物的综合理化、生物物理和体外表征。","authors":"David Encinas-Basurto, Priya Muralidharan, M D Saiful Islam, Ernest L Vallorz, Stephen M Black, Monica Kraft, Julie G Ledford, Heidi M Mansour","doi":"10.1039/d4pm00265b","DOIUrl":null,"url":null,"abstract":"<p><p>Surfactant protein-A (SP-A) is an endogenous and essential lung surfactant-specific protein that is integral to pulmonary immunity, including inhibition of asthma exacerbations. This study aims to comprehensively characterize two peptides (10-AA and 20-AA) of SP-A which confer activity similar to the full-length oligomeric SP-A protein. Spectroscopic and chromatographic analyses revealed that the phosphate (PS) and acetate (AC) salts exhibited distinct solubility and log <i>P</i> partitioning behavior, impacting their physicochemical properties. MD simulations and circular dichroism showed that SP-A 10-AA initially adopts an α-helical structure but loses helicity over time, while SP-A 20-AA remains disordered. Differential scanning calorimetry confirmed variations in thermal stability between salt forms and zeta potential measurements showed that PS salts had a more negative surface charge, potentially influencing membrane interactions. <i>In vitro</i> studies showed high cell viability (>90%) and stable TEER values at the air-liquid interface, confirming biocompatibility and potential epithelial permeability. These findings provide crucial insights into the structural and functional properties of SP-A peptides, supporting their potential as therapeutic agents for pulmonary diseases.</p>","PeriodicalId":101141,"journal":{"name":"RSC Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12053052/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comprehensive physicochemical, biophysical, and <i>in vitro</i> characterization of lung surfactant SP-A peptidomimetics.\",\"authors\":\"David Encinas-Basurto, Priya Muralidharan, M D Saiful Islam, Ernest L Vallorz, Stephen M Black, Monica Kraft, Julie G Ledford, Heidi M Mansour\",\"doi\":\"10.1039/d4pm00265b\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Surfactant protein-A (SP-A) is an endogenous and essential lung surfactant-specific protein that is integral to pulmonary immunity, including inhibition of asthma exacerbations. This study aims to comprehensively characterize two peptides (10-AA and 20-AA) of SP-A which confer activity similar to the full-length oligomeric SP-A protein. Spectroscopic and chromatographic analyses revealed that the phosphate (PS) and acetate (AC) salts exhibited distinct solubility and log <i>P</i> partitioning behavior, impacting their physicochemical properties. MD simulations and circular dichroism showed that SP-A 10-AA initially adopts an α-helical structure but loses helicity over time, while SP-A 20-AA remains disordered. Differential scanning calorimetry confirmed variations in thermal stability between salt forms and zeta potential measurements showed that PS salts had a more negative surface charge, potentially influencing membrane interactions. <i>In vitro</i> studies showed high cell viability (>90%) and stable TEER values at the air-liquid interface, confirming biocompatibility and potential epithelial permeability. These findings provide crucial insights into the structural and functional properties of SP-A peptides, supporting their potential as therapeutic agents for pulmonary diseases.</p>\",\"PeriodicalId\":101141,\"journal\":{\"name\":\"RSC Pharmaceutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12053052/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"RSC Pharmaceutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1039/d4pm00265b\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1039/d4pm00265b","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
表面活性剂蛋白- a (SP-A)是一种内源性和必需的肺表面活性剂特异性蛋白,是肺免疫不可或缺的一部分,包括抑制哮喘恶化。本研究旨在全面表征SP-A的两种肽(10-AA和20-AA),这两种肽具有与SP-A蛋白全长低聚体相似的活性。光谱和色谱分析表明,磷酸(PS)和乙酸(AC)盐表现出不同的溶解度和对数P分配行为,影响了它们的理化性质。MD模拟和圆二色性表明,SP-A - 10-AA最初呈α-螺旋结构,但随着时间的推移逐渐失去螺旋结构,而SP-A - 20-AA则保持无序结构。差示扫描量热法证实了盐形态之间热稳定性的变化,zeta电位测量表明PS盐具有更多的负表面电荷,可能影响膜的相互作用。体外研究显示高细胞活力(>90%)和稳定的气液界面TEER值,证实了生物相容性和潜在的上皮通透性。这些发现为SP-A肽的结构和功能特性提供了重要的见解,支持它们作为肺部疾病治疗剂的潜力。
Comprehensive physicochemical, biophysical, and in vitro characterization of lung surfactant SP-A peptidomimetics.
Surfactant protein-A (SP-A) is an endogenous and essential lung surfactant-specific protein that is integral to pulmonary immunity, including inhibition of asthma exacerbations. This study aims to comprehensively characterize two peptides (10-AA and 20-AA) of SP-A which confer activity similar to the full-length oligomeric SP-A protein. Spectroscopic and chromatographic analyses revealed that the phosphate (PS) and acetate (AC) salts exhibited distinct solubility and log P partitioning behavior, impacting their physicochemical properties. MD simulations and circular dichroism showed that SP-A 10-AA initially adopts an α-helical structure but loses helicity over time, while SP-A 20-AA remains disordered. Differential scanning calorimetry confirmed variations in thermal stability between salt forms and zeta potential measurements showed that PS salts had a more negative surface charge, potentially influencing membrane interactions. In vitro studies showed high cell viability (>90%) and stable TEER values at the air-liquid interface, confirming biocompatibility and potential epithelial permeability. These findings provide crucial insights into the structural and functional properties of SP-A peptides, supporting their potential as therapeutic agents for pulmonary diseases.